Current Clinical Oncology

Targeted Therapeutics in Melanoma

Editors: Gajewski, Thomas F., Hodi, F. Stephen (Eds.)

  • Describes both established signal transduction inhibitors as well as emerging molecularly-guided immunotherapies
  • Places exciting developments in basic biological understanding into a practical clinical context
  • The first book on melanoma devoted entirely to targeted therapeutics
  • Includes the most up-to-date data from current clinical Phase I-III trials
  • Written by high-profile authors representing the world’s leaders in their field
see more benefits

Buy this book

eBook $199.00
price for USA (gross)
  • ISBN 978-1-61779-407-0
  • Digitally watermarked, DRM-free
  • Included format: PDF, EPUB
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $259.00
price for USA
  • ISBN 978-1-61779-406-3
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $259.00
price for USA
  • ISBN 978-1-62703-876-8
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Rent the ebook  
  • Rental duration: 1 or 6 month
  • low-cost access
  • online reader with highlighting and note-making option
  • can be used across all devices
About this book

Melanoma is an increasingly important public health problem. Although the cause of most malignant melanomas – over-exposure to ultraviolet light – is well known, effective treatment has remained challenging.

The past several years have been marked by extraordinary developments in melanoma treatment in the arena of targeted therapeutics. This book describes these ground-breaking discoveries and their implications for clinical use. As melanoma biology is increasingly understood, so the development of targeted therapies for this disease is spurred ahead. This book covers both established signal transduction inhibitors and the fascinating emerging realm of molecularly-guided immunotherapies.

This benchmark book provides the most up-to-date information on the new breed of melanoma therapies. Composed of the works of major researchers and clinicians, this book offers new insights, novel approaches, and promising data for effective treatment planning. Illuminating the latest advances in the field, it is a solid resource for clinical oncologists, translational scientists, and basic cancer researchers.

Reviews

From the reviews:

“This book is a multiauthored edition, with contributors and editors who are experts in their fields regarding new therapeutic approaches for melanoma. … It is a highly technical volume and is directed toward true melanoma mavins, both clinical and laboratory research based, who continue to work at the translational interface. … I recommend this to all those clinical, translational, and laboratory investigators committed to moving the field forward in the development of treatment for melanoma.” (Janice P. Dutcher, Medical Oncology, Vol. 30, 2013)

Table of contents (18 chapters)

  • Molecular Targets and Subtypes in Melanoma

    Davies, Michael A.

    Pages 3-15

  • Melanoma Genomics

    Kashani-Sabet, Mohammed

    Pages 17-25

  • Predictive Biomarkers as a Guide to Future Therapy Selection in Melanoma

    Gajewski, Thomas F.

    Pages 27-40

  • KIT as a Therapeutic Target for Melanoma

    Ibrahim, Nageatte (et al.)

    Pages 43-61

  • Targeted Inhibition of B-Raf

    Chapman, Paul B. (et al.)

    Pages 63-76

Buy this book

eBook $199.00
price for USA (gross)
  • ISBN 978-1-61779-407-0
  • Digitally watermarked, DRM-free
  • Included format: PDF, EPUB
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $259.00
price for USA
  • ISBN 978-1-61779-406-3
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $259.00
price for USA
  • ISBN 978-1-62703-876-8
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Rent the ebook  
  • Rental duration: 1 or 6 month
  • low-cost access
  • online reader with highlighting and note-making option
  • can be used across all devices
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Targeted Therapeutics in Melanoma
Editors
  • Thomas F. Gajewski
  • F. Stephen Hodi
Series Title
Current Clinical Oncology
Copyright
2012
Publisher
Humana Press
Copyright Holder
Springer Science+Business Media, LLC
eBook ISBN
978-1-61779-407-0
DOI
10.1007/978-1-61779-407-0
Hardcover ISBN
978-1-61779-406-3
Softcover ISBN
978-1-62703-876-8
Series ISSN
2364-1134
Edition Number
1
Number of Pages
XIV, 378
Topics